Urinary Neopterin in Patients Treated with Gefitinib

Urinary Neopterin in Patients Treated with Gefitinib

Inhibitors of epidermal growth factor receptor (EGFR), including low molecular weight inhibitor erlotinib and gefitinib, have been demonstrated to be active antitumor agents in patients with non-small cell lung carcinoma and head and neck carcinomas. Increased concentrations of urinary neopterin, an...

Full description

Bibliographic Details
Main Authors: Kalabova Hana, Dvorak Josef, Hyspler Radomír, Ticha Alena, Krcmova Lenka, Urbanek Lubor, Solichova Dagmar, Melichar Bohuslav
Format: Article
Language:English
Published: De Gruyter 2007-02-01
Series:Pteridines
Subjects:
gefitinib
head and neck cancer
intestinal permeability
lung cancer
neopterin
Online Access:https://doi.org/10.1515/pteridines.2007.18.1.95

Internet

https://doi.org/10.1515/pteridines.2007.18.1.95

Similar Items